The fifth edition of the World Health Organization Classification of Tumours of the Central Nervous System (WHO CNS5) published in 2021 builds on the 2016 edition and …
ST Jünger, B Timmermann, T Pietsch - Child's Nervous System, 2021 - Springer
Pediatric ependymomas comprise biologically distinct tumor entities with different (epi) genetics, age distribution and localization, as well as a different prognosis. Regarding risk …
HB Lindsay, M Massimino, S Avula, S Stivaros… - The Lancet …, 2022 - thelancet.com
Response criteria for paediatric intracranial ependymoma vary historically and across different international cooperative groups. The Response Assessment in the Pediatric Neuro …
P Leblond, M Massimino, M English… - Frontiers in …, 2022 - frontiersin.org
Background: The clinical management of ependymoma in childhood and adolescence is complex and the clinicobiopathological correlates of outcome remain poorly understood …
TA Ritzmann, RJ Chapman, JP Kilday, N Thorp… - Neuro …, 2022 - academic.oup.com
Abstract Background SIOP Ependymoma I was a non-randomised trial assessing event free and overall survival (EFS/OS) of non-metastatic intracranial ependymoma in children aged 3 …
K Lutz, ST Jünger, M Messing-Jünger - Children, 2022 - mdpi.com
Brain tumors are the most common solid tumors in children and are associated with high mortality. The most common childhood brain tumors are grouped as low-grade gliomas …
L Bertero, AA Ricci, C Tampieri, P Cassoni… - Pathologica, 2022 - ncbi.nlm.nih.gov
Ependymal neoplasms are a heterogenous group of neoplasms arising from the progenitors of the cells lining the ventricular system and the spinal central canal. During the last few …
M Zaytseva, L Papusha, G Novichkova, A Druy - Cancers, 2021 - mdpi.com
Simple Summary The current trend in neuropathology directs to the integrated histo- molecular approach. The traditional concept of histological grade should be complemented …
DC Bowers, V Rajaram, MA Karajannis… - Neuro-Oncology …, 2023 - academic.oup.com
Background Preclinical studies have suggested that mTOR pathway signaling may be a potential therapeutic target for childhood ependymoma. Methods A phase II clinical trial …